© 2005 European Society of Cardiology
Clinical determinants of poor six-minute walk test performance in patients with left ventricular systolic dysfunction and no major structural heart disease
Department of Cardiology, Castle Hill Hospital Castle Road, Cottingham, Hull, HU16 5JQ, UK
* Corresponding author. Tel.: +44 148 262 3732; fax: +44 148 262 4071. E-mail address: L.Ingle{at}hull.ac.uk
 |
Abstract |
|---|
Background: The clinical determinants of six-minute walk test (6-MWT) performance in patients with left ventricular systolic dysfunction (LVSD) have rarely been investigated, and it is not clear whether they differ from patients referred for the assessment of symptoms of heart failure who do not have major structural heart disease (MSHD).
Methods and Results: 571 patients with LVSD enrolled in a chronic disease management programme (79% male; mean age 71±10 years; BMI 28±5) completed a 6-MWT with a mean distance 337±103 m. 688 patients referred with suspected heart failure but in whom MSHD was excluded (49% male; mean age 70±11 years; BMI 28±6) had a mean 6-MWT distance of 391±106 m (P<0.001 compared to patients with LVSD). Relationships with walking distance were determined by calculating odds ratios (ORs) with 95% confidence intervals (CIs) for walking 
300 versus >300 m. In patients with LVSD, predictors of poor walking distance (300 m) included age 
75 years (OR=4.0, 95% CI=2.4–6.4); low BMI (<20) (OR=3.4, 95% CI=1.6–7.3); anaemia (OR=2.8, 95% CI=1.8–4.2); resting heart rate >80 beats min–1 (OR=2.2, 95% CI=1.3–3.5); and being female (OR=2.0, 95% CI=1.3–3.0). Serum creatinine and NT-proBNP showed dose–response effects, as did self-perceived feelings of depression and anxiety. Determinants of 6-MWT in patients without MSHD were similar including age 75 years (OR=6.0, 95% CI=3.4–10.4), anaemia (OR=2.8, 95% CI=1.6–4.9), resting HR >80 beats min–1 (OR=2.5, 95% CI=1.4–4.4) and being female (OR=1.6, 95% CI=1.9–2.4). NT-proBNP and self-perceived feelings of depression and anxiety also showed dose–response effects.
Conclusion: The determinants of poor 6-MWT performance depend on physical–cardiovascular and non-cardiovascular, and psychological factors. Clinical predictors for poor walking performance are similar for patients with LVSD and without MSHD.
Key Words: Clinical determinants • Poor 6-MWT performance • LVSD • No MSHD
Received April 5, 2005; Revised July 20, 2005; Accepted August 25, 2005
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. T. Parissis, D. Farmakis, M. Nikolaou, D. Birmpa, V. Bistola, I. Paraskevaidis, I. Ikonomidis, S. Gaitani, K. Venetsanou, G. Filippatos, et al. Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1-year follow-up study Eur J Heart Fail, October 1, 2009; 11(10): 967 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J T Parissis, M Nikolaou, D Farmakis, V Bistola, I A Paraskevaidis, S Adamopoulos, G Filippatos, and D T Kremastinos Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure Heart, May 1, 2008; 94(5): 585 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Metra, P. Ponikowski, K. Dickstein, J. J.V. McMurray, A. Gavazzi, C.-H. Bergh, A. G. Fraser, T. Jaarsma, A. Pitsis, P. Mohacsi, et al. Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail, June 1, 2007; 9(6-7): 684 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ingle, A. S. Rigby, S. Carroll, R. Butterly, R. F. King, C. B. Cooke, J. G.J.F. Cleland, and A. L. Clark Prognostic value of the 6 min walk test and self-perceived symptom severity in older patients with chronic heart failure Eur. Heart J., March 1, 2007; 28(5): 560 - 568. [Abstract] [Full Text] [PDF]
|
|